P2X5 and P2X7 receptors in human warts and CIN-612 organotypic raft cultures of human papillomavirus infected keratinocytes

Purinergic Signalling

Volumn 2, Issue 3, 2006, Pages 509-515

  Greig, Aina V H ^a   Cuthill, Scott ^b   Linge, Claire ^c   Clayton, Elizabeth ^c   Burnstock, Geoffrey ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b OSI Pharmaceuticals   (United Kingdom)

^c MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Human papillomavirus; Purinergic receptor; Raft culture; Warts

Indexed keywords

EID: 33748541650     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-005-5035-5     Document Type: Article

References (37)

1. Miller DL, Weinstock DA. Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Dermatol 1994; 30: 774-8.
2. Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol 1994; 131: 455-64.
3. de Villiers E-M, Lavergne D, McLaren K, Benton EC. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997; 73: 356-61.
4. Walder BK, Robertson MR, Jeremy D. Skin cancer and immunosuppression. Lancet 1971; 11: 1282-3.
5. Abbracchio MP, Burnstock G. Purinergic signalling: Pathophysiological roles. Jpn J Pharmacol 1998; 78: 113-45.
6. Burnstock G. Purinergic signalling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 2002; 22: 364-73.
7. Burnstock G. A basis for distinguishing two types of purinergic receptor. In Straub RW, Bolis L (eds): Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach. New York: Raven Press, 1978; 107-18.
8. 2-purinoceptor? Gen Pharmacol 1985; 16: 433-40.
9. Abbracchio MP, Burnstock G. Purinoceptors: Are there families of P 2X and P 2Y purinoceptors? Pharmacol Ther 1994; 64: 445-75.
10. Khakh BS, Burnstock G, Kennedy C et al. International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 2001; 53: 107-18.
11. Burnstock, G. Introduction: ATP and Its Metabolites as Potent Extracellular Agents. In Schwiebert EM (ed): Current Topics in Membranes. Purinergic Receptors and Signalling. Vol. 54, San Diego: Academic Press, 1-27.
12. Hoebertz A, Townsend-Nicholson A, Glass R et al. Expression of P2 receptors in bone and cultured bone cells. Bone 2000; 27: 503-10.
13. Ryten M, Dunn PM, Neary JT, Burnstock G. ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X 5 receptor on satellite cells. J Cell Biol 2002; 158: 345-55.
14. Coutinho-Silva R, Persechini PM, Bisaggio RD et al. P2Z/P2X 7 receptor-dependent apoptosis of dendritic cells. Am J Physiol 1999; 276: C1139-47.
15. Di Virgilio F, Chiozzi P, Ferrari D et al. Nucleotide receptors: An emerging family of regulatory molecules in blood cells. Blood 2001; 97: 587-600.
16. 7 receptors by immunohistochemistry in rat stratified squamous epithelia. Cell Tissue Res 1999; 296: 599-605.
17. Greig AVH, Linge C, Terenghi G et al. Purinergic receptors are part of a functional signalling system for proliferation and differentiation of human epidermal keratinocytes. J Invest Dermatol 2003; 120: 1007-15.
18. Greig AVH, Linge C, Healy V et al. Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells. J Invest Dermatol 2003; 121: 315-27.
19. Greig AVH, Linge C, Cambrey A, Burnstock G. Purinergic receptors are part of a signalling system for keratinocyte proliferation, differentiation and apoptosis in human fetal epidermis. J Invest Dermatol 2003; 121: 1145-9.
20. Greig AVH, James SE, McGrouther DA et al. Purinergic receptor expression in the regenerating epidermis in a rat model of normal and delayed wound healing. Exp Dermatol 2003; 12: 860-71.
21. 5Ozbun MA, Meyers C. Transforming growth factor β1 induces differentiation in human papillomavirus-positive keratinocytes. J Virol 1996; 70: 5437-46.
22. 7. Drug Dev Res 1999; 47: 189-95.
23. Proby CM, Storey A, McGregor J, Leigh IM. Does human papilloma virus infection play a role in no-melanoma skin cancer? Papillomavirus Rep 1996; 7: 53-60.
24. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996; 1288: 55-78.
25. Blessing K, McLaren KM, Benton EC et al. Histopathology of skin lesions in renal allograft recipients - an assessment of viral features and dysplasia. Histopathology 1989; 14: 129-39.
26. Zheng LM, Zychlinsky A, Liu CC et al. Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol 1991; 112: 279-88.
27. Ferrari D, Villalba M, Chiozzi P et al. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J Immunol 1996; 156: 1531-9. 1531-9.
28. Cook MG, McKee PH. Infectious diseases. In McKee PH (ed) Pathology of the Skin. London: Gower Medical Publishers, 1989; 4.2-.7.
29. Majewski S, Jablonska S. Human papillomavirus-associated tumours of the skin and mucosa. J Am Acad Dermatol 1997; 36: 659-85.
30. zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-50.
31. Gissman L, Boshart M, Durst M et al. Presence of human papillomavirus in genital tumours. J Invest Dermatol 1984; 83: 26s-8s.
32. Favre M, Orth G, Majewski S et al. Psoriasis: A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 1998; 110: 311-7.
33. Weissenborn SJ, Hopfl R, Weber F et al. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA. J Invest Dermatol 1999; 113: 122-6.
34. Ryten M, Hoebertz A, Burnstock G. Sequential expression of three receptor subtypes for extracellular ATP in developing rat skeletal muscle. Dev Dyn 2001; 221: 331-41.
35. Kopan R, Traska G, Fuchs E. Retinoids as important regulators of terminal differentiation: Examining keratin expression in individual epidermal cells at various stages of keratinization. J Cell Biol 1987; 105: 427-40.
36. 7). Science 1996; 272: 735-8.
37. Ferrari D, Los M, Bauer MK et al. P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett 1999; 19: 71-5.